- Home
- CNEY vs ISPC Comparison
CNEY vs ISPC Comparison
Compare CNEY & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNEY
- ISPC
- Stock Information
- Founded
- CNEY 2018
- ISPC 2009
- Country
- CNEY China
- ISPC United States
- Employees
- CNEY N/A
- ISPC N/A
- Industry
- CNEY Major Chemicals
- ISPC Precision Instruments
- Sector
- CNEY Industrials
- ISPC Health Care
- Exchange
- CNEY Nasdaq
- ISPC Nasdaq
- Market Cap
- CNEY 12.4M
- ISPC 13.9M
- IPO Year
- CNEY 2021
- ISPC 2021
- Fundamental
- Price
- CNEY $2.27
- ISPC $0.94
- Analyst Decision
- CNEY
- ISPC
- Analyst Count
- CNEY 0
- ISPC 0
- Target Price
- CNEY N/A
- ISPC N/A
- AVG Volume (30 Days)
- CNEY 386.2K
- ISPC 12.3M
- Earning Date
- CNEY 01-01-0001
- ISPC 11-06-2025
- Dividend Yield
- CNEY N/A
- ISPC N/A
- EPS Growth
- CNEY N/A
- ISPC N/A
- EPS
- CNEY N/A
- ISPC N/A
- Revenue
- CNEY $36,049,275.00
- ISPC $5,908,088.00
- Revenue This Year
- CNEY N/A
- ISPC $35.93
- Revenue Next Year
- CNEY N/A
- ISPC N/A
- P/E Ratio
- CNEY N/A
- ISPC N/A
- Revenue Growth
- CNEY N/A
- ISPC N/A
- 52 Week Low
- CNEY $1.56
- ISPC $0.64
- 52 Week High
- CNEY $21.61
- ISPC $8.30
- Technical
- Relative Strength Index (RSI)
- CNEY 46.21
- ISPC 40.84
- Support Level
- CNEY $2.18
- ISPC $1.13
- Resistance Level
- CNEY $2.95
- ISPC $1.33
- Average True Range (ATR)
- CNEY 0.20
- ISPC 0.18
- MACD
- CNEY -0.02
- ISPC -0.05
- Stochastic Oscillator
- CNEY 16.87
- ISPC 1.61
About CNEY CN Energy Group Inc.
CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.